Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-162396)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R21EY025074)
Canada Research Chairs
Article History
Received: 30 June 2021
Revised: 17 August 2021
Accepted: 26 August 2021
First Online: 17 September 2021
Competing interests
: L.A.L. is a consultant or advisory board member on neuroprotection and neuroregeneration for Aerie, Eyevensys, Genentech, Perfuse, Quark, Regenera, Santen, Gilbert Family Foundation, and the National Eye Institute. He is an inventor on patents for phosphine-borane complexes, which were assigned to the Wisconsin Alumni Research Foundation.
: All animal experiments were conducted in accordance with the guidelines of the Canadian Council on Animal Care and approved by the Montreal Neurological Institute and McGill University Animal Ethics Committees.